Thermo Fisher Scientific

Where forward-thinking scientists, educators and safety professionals come to share and discover information that makes the world a cleaner, safer & healthier place to live.

  • Categories
    • Advancing Materials
    • Advancing Mining
    • AnalyteGuru
    • Analyzing Metals
    • Ask a Scientist
    • Behind the Bench
    • Biotech at Scale
    • Clinical Conversations
    • Examining Food
    • Identifying Threats
    • Illuminating Semiconductors
    • Life in Atomic Resolution
    • Life in the Lab
    • OEMpowered
    • The Connected Lab
  • About Us
  • Contact

Expertise

BioprocessingIntegrated Workflow StrategyMonoclonal antibodiesSales enablement

Education

PhD in Cell and Molecular Biology, MSc in Microbiology from the University of Turku

Pirkko Muhonen, PhD

Global Integrated Programs Manager, Thermo Fisher Scientific

Pirkko Muhonen, PhD, is a Global Integrated Programs Manager at Thermo Fisher Scientific with over 15 years of experience spanning research, bioprocessing, and commercial strategy. She holds a PhD in Biochemistry, Cell and Molecular Biology and an MSc in Biochemistry (Microbiology) from the University of Turku.

She drives cross-functional programs that connect research, development, and commercial teams to deliver integrated workflow strategies for protein-based therapeutics including monoclonal antibodies. Her work focuses on translating complex scientific and economic insights into structured, value-based approaches that support strategic growth and informed decision-making. By aligning technical expertise with market needs, she ensures scientific rigor while advancing scalable, end-to-end solutions.

Life in the Lab

From Titer to Throughput: How Integrated Process Intensification Is Reshaping mAb Manufacturing

From Titer to Throughput: How Integrated Process Intensification Is Reshaping mAb Manufacturing

March 24, 2026

Read more From Titer to Throughput: How Integrated Process Intensification Is Reshaping mAb Manufacturing
mAb Manufacturing

Scaling mAb Manufacturing: Turning Lab Success into Commercial Performance

February 23, 2026

Read more Scaling mAb Manufacturing: Turning Lab Success into Commercial Performance

Privacy StatementTerms & ConditionsLocationsSitemap

© 2026 Thermo Fisher Scientific. All Rights Reserved.

US

Talk to us